Clarity Medical Sets 15 Sept 2026 Board Meeting to Clear FY25–26 Accounts; Share Trading Still Halted

Bulletin Express09-03

Clarity Medical Group Holding Limited has slated a board meeting for 15 September 2026. Directors will review and approve the audited financial statements for the fiscal years ended 31 March 2025 and 31 March 2026, as well as the interim results for the six months ended 30 September 2025. Potential declarations of final and interim dividends will also be considered during the session.

Trading in Clarity Medical’s shares has been suspended since 09:00 a.m. on 15 April 2025 and will remain halted until further notice, according to the company. The board advises shareholders and prospective investors to exercise caution when dealing in the company’s securities.

The current board comprises one executive director (Mr Jiang Bo, who also serves as Chief Executive Officer), three non-executive directors and four independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment